Almost half of currently marketed drug products, and around 90 percent of those in clinical development are associated with poor drug solubility or permeability.
In this white paper, we discuss the basics of solubility enhancement and the formulation and manufacture of products that enhance solubility. We also address common questions on the topic.
Author:
Dr. Thomas Endres, Evonik Operations GmbH, Darmstadt, Germany
